Influence of thyroid hormone receptors on breast cancer cell proliferation

Annals of Oncology

Volumn 17, Issue 1, 2006, Pages 60-64

  Conde, I ^a   Paniagua, R ^a   Zamora, J ^b   Blanquez M J ^c   Fraile, B ^a   Ruiz, A ^d   Arenas, M Isabel ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^d HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

Author keywords

Breast; Cancer; Proliferation; Thyroid hormone receptors

Indexed keywords

THYROID HORMONE RECEPTOR ALPHA; THYROID HORMONE RECEPTOR BETA;

ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST CARCINOMA; BREAST CELL; BREAST DISEASE; CARCINOMA IN SITU; CELL NUCLEUS; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOPLASM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; WESTERN BLOTTING;

EID: 29844453468     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdj040     Document Type: Article

References (27)

1. Demers LM. Thyroid disease: Pathophysiology and diagnosis, Clin Lab Med 2004; 24: 19-28,
2. Beatson GT. On the treatment of inoperable cancer of the mamma: suggestions for a new method of treatment with illustrative cases, Lancet 1896; 2: 104-165.
3. Guernesey DL. Thyroid hormone action. Cancer J 1993; 6: 253-256.
4. Smyth PPA. The thyroid and breast cancer: A significant association? Ann Med 1997; 29: 189-191.
5. Yokoe T, Iino Y, Takei H et al. Relationship between thyroid-pituitary function and response to therapy in patients with recurrent breast cancer. Anticancer Res 1996; 16: 2069-2072.
6. Yokoe T, Iino Y, Takei H et al. Changes of cytokines and thyroid function in patients with recurrent breast cancer. Anticancer Res 1997; 17: 695-699.
7. Vonderhaar BK, Greco A. Lobulo-alveolar development of mouse mammary glands is regulated by thyroid hormones. Endocrinology 1979; 104: 409-418.
8. López-Barahona M, Fialka I, González-Sancho JM et al. Thyroid hormone regulates stromelysin expression, pretease secretion and the morphogenetic potential of normal polarized mammary epithelial cells. EMBO J 1995; 14: 1145-1155.
9. González-Sancho JM, Figueroa A, López-Barahona M et al. Inhibition of proliferation and expression of T1 and cyclin D1 genes by thyroid hormone in mammary epithelial cells. Mol Carcinog 2002; 34: 25-34.
10. Smallridge RC, Latham KR. Nuclear thyroid hormone receptor in human breast tumors, Clinical Res 1980; 28: 421.
11. Alvarado-Pisani AR, Chacon RS, Betancourt LJ et al. Thyroid hormone receptors in human breast cancer: Effect of thyroxine administration. Anticancer Res 1986; 6: 1347-1351.
12. Burke RE, McGuire WL. Nuclear thyroid hormone receptors in a human breast cancer cell line. Cancer Res 1978; 38: 3769-3773.
13. Zhou-Li F, Albaladejo V, Joly-Pharaboz MO et al. Antiestrogens prevent the stimulatory effects of L-triiodothyronine on cell proliferation. Endocrinology 1992; 130: 1145-1152.
14. Martinez MB, Ruan M, Fitzpatrick LA. Altered response to thyroid hormones by prostate and breast cancer cells. Cancer Chemother Pharmacol 2000; 45: 93-102.
15. Garcia-Silva S, Aranda A. The thyroid hormone receptor is a suppressor of ras-mediated transcription, proliferation, and transformation. Mol Cell Biol 2004; 24: 7514-7523.
16. Hsu SM, Soban E. Colour modification of diaminobenzidine (DAB) precipitation by metallic ions and its application for double immunohistochemistry. J Histochem Cytochem 1982; 30: 1079-1082.
17. Connolly KM, Bogdanffy S. Evaluation of proliferating cell nuclear antigen (PCNA) as an endogenous marker of cell proliferation in rat liver: A dual-stain comparison with 5-bmmo 2′ deoxyuridine. J Histochem Cytochem 1993; 41: 1-6.
18. Silva JM, Dominguez G, Gónzalez-Sancho JM et al. Expression of thyroid hormone receptor/erbA genes is altered in human breast cancer. Oncogene 2002; 21: 4307-4316,
19. Shering SG, Zbar AP, Moriarty M et al. Thyroid disorders and breast cancer. Eur J Cancer Prey 1996; 5: 504-506.
20. Saraiva PP, Figuelredo NB, Padovani CR et al. Profile of thyroid hormones in breast cancer patients. Braz J Med Biol Res 2005; 38: 761-765,
21. González-Sancho JM, Garcia V, Bonilla F et al. Thyroid hormone receptors/THR genes in human cancer. Cancer Lett 2003; 192: 121-132.
22. Lee Y, Mahdavi V. The D domain of the thyroid hormone receptor alpha 1 specifies positive and negative transcriptional regulation functions. J Biol Chem 1993; 268: 2021-2028.
23. Chytil A, Waltner-Law M, West R et al. Construction of a cyclin D1-Cdk2 fusion protein to model the biological functions of cyclin D1-Cdk2 complexes. J Biol Chem 2004; 279: 47688-14698.
24. Li J, Lin Q, Yoon HG et al. Involvement of histone methylation and phosphorylation in regulation of transcription by thyroid hormone receptor. Mol Cell Biol 2002; 22: 5688-5697.
25. Fasco MJ, Keyomarsi K, Arcaro KF et al. Expression of an estrogen receptor α variant protein in cell lines and tumors, Mol Cell Endocrinol 2000; 166: 156-199.
26. Lukas J, Gao D-Q, Keshmeshian M et al. Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer. Cancer Res 2001; 61: 3212-3219.
27. Puzianowska-Kuznicka M, Nauman A, Madej A et al. Expression of thyroid hormone receptors is disturbed in human renal clear cell carcinoma. Cancer Lett 2000; 155: 145-152.